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Neonatal pneumococcal 
colonisation caused by Influenza 
A infection alters lung function in 
adult mice
Meaghan FitzPatrick2, Simon G. Royce5, Shenna Langenbach2, Jonathan McQualter2, 
Patrick C. Reading3, Odilia Wijburg4, Gary P. Anderson2, Alastair Stewart2, Jane Bourke2,5 & 
Steven Bozinovski1,2
There is emerging epidemiological data to suggest that upper respiratory tract bacterial colonisation 
in infancy may increase the risk of developing respiratory dysfunction later in life, and respiratory 
viruses are known to precipitate persistent colonisation. This study utilized a neonatal mouse model of 
Streptococcus pneumonia (SP) and influenza A virus (IAV) co-infection, where bronchoalveolar leukocyte 
infiltration had resolved by adulthood. Only co-infection resulted in persistent nasopharyngeal 
colonisation over 40 days and a significant increase in airway resistance in response to in vivo 
methacholine challenge. A significant increase in hysteresivity was also observed in IAV and co-infected 
mice, consistent with ventilatory heterogeneity and structural changes in the adult lung. Airway 
hyper-responsiveness was not associated with a detectable increase in goblet cell transdifferentiation, 
peribronchial smooth muscle bulk or collagen deposition in regions surrounding the airways. Increased 
reactivity was not observed in precision cut lung slices challenged with methacholine in vitro. 
Histologically, the airway epithelium appeared normal and expression of epithelial integrity markers 
(ZO-1, occludin-1 and E-cadherin) were not altered. In summary, neonatal co-infection led to persistent 
nasopharyngeal colonisation and increased airway responsiveness that was not associated with 
detectable smooth muscle or mucosal epithelial abnormalities, however increased hysteresivity may 
reflect ventilation heterogeneity.
Influenza-associated hospitalization rates in children younger than 5 years old are exceeded only by the elderly1. 
Globally, it has been estimated that around 20 million cases of influenza infections occur worldwide in children 
younger than 5 years, which accounts for 13% of paediatric cases of acute lower respiratory tract infections2. 
Infants aged less than one year have been reported to be even more susceptible to influenza-associated hospi-
talizations3, which is consistent with children under the age of 6 months being too young for vaccination. The 
clinical response to different viral strains can vary from mild disease to severe pneumonia, and immunological 
and inflammatory profiles have been extensively characterised, where pandemic strains are more likely to initiate 
an exaggerated inflammatory response that culminates in severe lung injury4.
Young children also represent a major reservoir for Streptocococcus pneuemoniae (SP) carriage5, which is the 
predominant microbe responsible for bacterial pneumonia. Although there are multiple environmental, host and 
microbiological factors that increase an individual’s susceptibility to pneumococcal disease, infection with IAV in 
particular, has been associated with an increase in pneumocococcal burden6. Notably, concurrent IAV infection 
is essential for the transmission of SP from colonised mice to their naive co-housed littermates, as transmission 
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could be prevented by inhibiting viral replication7. The detection of bacteria that can colonise the airways occurs 
frequently during significant bronchiolitis episodes; hence the common terminology of viral wheeze may not 
accurately reflect the aetiological nature of many acute events in children under the age of 5 years8,9. Neonatal 
upper airway colonisation is also associated with increased risk of bronchiolitis in early life independent of 
concurrent asthma10. There are also emerging epidemiological data to suggest that asymptomatic nasopharyn-
geal bacterial colonisation is associated with persistent wheeze in children, where the prevalence of asthma at 5 
years of age was significantly increased in the children colonised as neonates in the hypopharyngeal region with 
microbes including SP11.
It has also been established that influenza and other viruses can acutely alter lung function and lead to airway 
hyper-responsiveness (AHR) in response to increasing concentrations of constrictor agonists, such as methacho-
line (MCh)12. Using a low-frequency, forced oscillation technique, heightened responsiveness to both inhaled and 
intravenous MCh has been observed during the acute phase of influenza A virus (IAV) infection in mice. In this 
study, no intrinsic smooth muscle defect was observed, but rather an increase in permeability of the alveolar–cap-
illary barrier was facilitating greater MCh access to airway smooth muscle13. Furthermore, increased AHR was 
shown to be transient in nature as lung function normalised with resolution of inflammation and tissue injury in 
adult mice13. In contrast to adult mice, physiological and inflammatory responses to IAV infection were assessed 
in infant mice, where residual AHR persisted for 21 days when inflammation and alveolar–capillary permeabil-
ity had fully resolved14. In the current study, the effect of infant co-infection with SP and IAV on adult mouse 
lung function was assessed, revealing persistence of MCh-induced hyper-responsiveness that was independent of 
mucosal epithelial abnormalities.
Methods
Animals and Model of Neonatal Co-infection. Advanced pregnant C57BL/6 dams were obtained from 
Animal Resources Centre, Western Australia. Dams were housed separately and monitored for births, with min-
imal disruption. Upon birth, dams were housed with their litters in light-protected cages until weaning at 3–4 
weeks of age. Mice were housed at 22 °C under normal 12 : 12 h light : dark cycle, and given free access to a normal 
diet and water, and monitored for signs of illness or distress. All experimental procedures performed in mice were 
approved by the Animal Ethics Committee of the University of Melbourne (approval #1111986 & #1413288), 
complied with the National Health and Medical Research Council (NHMRC) Australian Code of Practice and 
were carried out in accordance with the approved guidelines. Neonatal mice were infected with SP and/or IAV 
as previously described7 with the following minor modifications. At 5 days of age, C57BL/6 mice were infected 
intranasally without anaesthesia with vehicle (sterile PBS) or SP (serotype 19F/EF3030, 2 × 103 CFU/mL) in a 
volume of 3 μL sterile PBS. At 12 days of age, mice were infected intranasally with vehicle (sterile PBS) or IAV 
(strain HK × 31, H3N2, 7 × 103 PFU/mL) in a volume of 3 μL sterile PBS.
Collection and Measurement of Specimens. Following neonatal challenge with SP and/or IAV, mice 
were allowed to recover and assessed starting at 6–8 weeks of age in early adulthood. At time of analysis, mice 
were euthanized by overdose of sodium pentobarbitone and bronchoalveolar lavage (BAL) was performed by 
tracheotomy and total and differential BAL cell counts determined as previously described15. Briefly, at time 
points prior to 6–8 weeks, nasopharyngeal and lung tissues were collected, homogenised and serial dilutions of 
tissue homogenates were cultured on horse blood agar plates to determine bacterial load as previously described7.
Measurement of Airway Hyperresponsiveness in vivo and in vitro. Lung function was measured 
using a modification of the low-frequency forced oscillation technique and a small-animal ventilator (flexiVent; 
Scireq, Montreal, QC, Canada) as described13. Respiratory impedance (Zrs) was measured and partitioned into 
airway and parenchymal components to allow calculation of Newtonian resistance (Rn, equivalent to airway 
resistance (Raw) because of the high compliance of the chest wall), tissue damping (G) and elastance (H), as 
previously described14. Airway inertance (Iaw) is negligible after correcting for the tracheal cannula and is not 
reported. Tissue hysteresivity (η ) was calculated as the ratio G/H16. Baseline respiratory mechanics was recorded, 
followed by saline aerosol and increasing doses of MCh delivered by an ultrasonic nebuliser (MCh; 1, 3, 10, 30, 
100 mg/mL). Differences in responsiveness were assessed as the maximum responses to 30 mg/mL MCh chal-
lenge. In vitro small airway reactivity in response to MCh was assessed via the precision cut lung slice technique 
as previously described17. Briefly, low-melting point agarose (GIBCO/Invitrogen, Australia) was used to inflate 
lungs, sequential slices (150 μm) using a vibratome (VT 1000 S, Leicamicrosystems) were cut and lung slices con-
taining intrapulmonary airways ranging from 150–300 μm in diameter were incubated at 37 °C and 5% CO2 for 
24 h prior to use in experiments.
Histology and Immunohistochemistry. The left lobe of lung was removed post mortem and immediately 
fixed in 10% neutral-buffered formalin. Tissues were paraffin-embedded and cut at a thickness of 5 μm. Sections 
were stained with H&E, Masson trichrome for assessment of epithelial and sub-epithelial collagen content or with 
Alcian blue–periodic acid-Schiff for assessment of goblet cell transdifferentiation. Morphometric evaluation of 
lung tissue sections was performed as described previously18. A minimum of five bronchi selected according to 
size (150 to 350 mm luminal diameter) were analysed per mouse. To assess the presence of airway smooth muscle 
bulk, primary antibody to anti-α smooth muscle actin (α -SMA, Dako, Glostrup, Denmark) was used and the 
thickness of labelled α -SMA per length of basement membrane measured in a minimum of 5 bronchi, as previ-
ously described19. Images of stained slides were captured using Aperio ImageScope software.
Quantitative Real-time PCR for gene expression analysis of lung tissue. RNA was purified from 
whole lung tissue using RNeasy kit as per manufacturer’s instructions and cDNA was prepared as previously 
described20. Taqman PCR primers were used to perform Q-PCR, where all threshold cycle values (Ct) were 
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normalized to control (glyceraldehyde phosphate dehydrogenase) and the relative fold change determined by the 
ΔΔCt value as previously described20.
Data analysis. Data and presented as the mean ± standard error of mean (SEM) for n mice. All data were 
statistically analysed using GraphPad Prism 5.0 (Graphpad, San Diego, CA). Where detailed and appropriate, 
one-way analyses of variance (ANOVA) with Bonferroni or Dunnett’s post-hoc tests were used. In other cases, 
unpaired Student’s t-tests were used to analyse data. p < 0.05 was considered to be statistically significant.
Results
Neonatal co-infection facilitates long term nasopharyngeal SP colonisation. An established 
co-infection model was used, where IAV is known to disrupt clearance of SP leading to a transient increase in 
nasopharyngeal and lower airway bacterial carriage in adult mice7. In our study, neonatal mice were infected 
and outcomes were assessed in early adulthood as described in Fig. 1A. Early life infection with SP and/or IAV 
did not have any long lasting effects on body weight of male and female mice across all groups into adulthood 
(Fig. 1B,C). To determine the chronicity of SP carriage in the upper and lower airways, a detailed kinetic study 
was performed. Bacterial load in nasopharyngeal (Fig. 2A) and lung (Fig. 2B) homogenates were assessed at time 
points of 20, 30 and 40 days of life. In neonatal mice infected with SP alone, transient nasopharyngeal carriage 
steadily declined to negligible levels by day 40 of life. This is in contrast to co-infected neonatal mice, where levels 
of SP upper airway carriage persisted over the kinetic study leading to a significant 1-log increase in load at Day 
40 relative to mice infected with SP alone (Fig. 2A).
In this model, there was no evidence for significant invasive dissemination of SP into the lower airway 
(Fig. 2B), suggesting that the bacteria localised predominately to the upper airways. In addition, the number of 
inflammatory leukocytes in the BAL compartment was assessed in adult mice following infection during neonatal 
phase of life. The data is indicative of the inflammatory process being fully resolved in response to IAV and/or 
SP as total, neutrophil and macrophages numbers were not altered (Fig. 3A–C). There was a small but significant 
increase in lymphocyte counts in co-infected mice compared to vehicle control (Fig. 3D). To determine whether 
the increase in BAL lymphocyte numbers were associated with an increase TH2 cytokines in the lung, QPCR was 
performed on IL-5 and IL-13, where no increase in expression was observed (Fig. 3E,F).
Figure 1. Model of neonatal respiratory co-infection. (A) Neonatal mice were infected with Streptococcus 
pneumonia (SP) at 5 days of age (or PBS vehicle) and co-infected with influenza A virus (IAV) at 12 days of age 
(or PBS vehicle, resulting in 4 treatment groups (vehicle, SP, IAV, SP/IAV). Exposure to infections in infancy 
did not alter somatic growth in male (B) or female (C) mice from age of weaning into adulthood (n = 4− 9 
representative of infant mice). LFT; lung function testing, BALF; bronchoalveolar lavage fluid.
www.nature.com/scientificreports/
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Co-infection with SP and IAV increased central airways resistance and hysteresivity. In mice 
co-infected with SP and IAV as neonates, baseline lung function responses were not different to that of vehicle 
treated mice. However newtonian resistance (Rn), which is equivalent to central airway resistance, increased at 
the higher doses of MCh, peaking at 30 mg/mL (Fig. 4A). MCh responses at 30 mg/mL were compared across all 
four groups and presented as a percentage change above nebulised saline response. The data demonstrates a sig-
nificant increase (p < 0.05) in central airway resistance (Rn) only in co-infected mice that was 2-fold higher than 
mice treated with vehicle as neonates (Fig. 4B). Baseline G (tissue damping), H (tissue elastance) and hysteresivity 
(G/H) were also assessed in adult mice treated with SP and IAV or vehicle in infancy. These additional measures 
of lung function also showed no difference at baseline (Fig. 5A,C,E). Infection in infancy did not significantly 
affect MCh-induced increases in G (Fig. 5A,B), The significant increase in MCh-induced H detected in vehicle 
and co-infected mice was absent in mice treated with either SP or IAV alone (Fig. 5C,D). Hysteresivity (η = G/H), 
which has been used to characterise tissue mechanics was shown to increase with increasing concentration of 
MCh in co-infected mice above vehicle treated mice (Fig. 5E). Maximal MCh responses across all four groups 
revealed a significant increase in η in both IAV and SP/IAV treated mice (Fig. 5F).
Assessment of airway remodelling in adult mice co-infected as neonates. To assess whether 
altered airway responsiveness was due to remodelling processes occurring in the lung, mucus and smooth mus-
cle was quantified histologically and via gene expression analysis of lung tissue. AB-PAS staining revealed no 
observable increase in goblet cell numbers across all groups (Fig. 6A–D), and the lack of goblet cell expansion 
was consistent with unchanged Muc5ac mucin gene expression (Fig. 6I). Immunohistochemical assessment 
of α -smooth muscle actin positive area surrounding airways expressed relative to basement membrane area 
revealed no significant difference across the treatment groups (Fig. 6J). In addition, in vitro airway reactivity was 
investigated in precision cut lung slices. Consistent with the absence of increased area for α -smooth muscle in 
vivo, contractile responses of size-matched intrapulmonary airways to MCh in vitro were unaltered between all 
treatment groups, where MCh caused a ~60% reduction in airway lumen area in all mice tested (Fig. 7A–C). Since 
mucin or smooth muscle abnormalities, were not detected, we considered the potential for epithelial disruption 
Figure 2. Persistent upper airway colonisation following neonatal co-infection. Bacterial burden in the 
upper airways (nasopharynx, (A)) and lower airways (whole lung, (B)) was assessed at 20, 30 and 40 days of age 
in SP and SP/IAV treated mice (n = 6− 9). Data are expressed as total colony-forming units in whole lung tissues 
that were homogenised and grown on horse-blood agar plates. *p < 0.05 compared to day 40 SP alone.
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contributing to increased airway responsiveness in vivo. Histologically, the epithelium appeared normal in all 
treatment groups and when quantified, epithelial thickness measures were comparable (Fig. 8A–E). Gene expres-
sion analysis of epithelial integrity markers including ZO-1, Occludin-1 and E-cadherin also yielded no signif-
icant differences across the treatment groups relative to vehicle treated mice, although there was a small trend 
towards a reduction in ZO-1 and Occludin-1 in co-infected mice (Fig. 8F–H). In addition, total protein concen-
tration was determined in the BALF as an alternative marker for barrier integrity. BALF protein levels in vehicle 
(538 ± 40), SP (565 ± 22), IAV (546 ± 15), SP + IAV (511 ± 36) μg/mL were not significantly different across the 
challenge groups. Additionally, FACS analysis whole lung tissue (Supplementary Figure S1) revealed no signif-
icant difference in the relative abundance of EpCAM+ MHCII+ AT2 cells in the non-hematopoietic (CD45−), 
non-endothelial (CD31−) cell fraction, which further demonstrates that there was no alteration in epithelial cell 
composition across the treatment groups. This data was consistent with no observed increase in surfactant protein 
C and D expression, as assessed by QPCR (supplementary figure 2).
Figure 3. Neonatal co-infection does not elicit TH2 immune response in adult lung. Bronchoalveolar lavage 
fluid from adult mice exposed to infant co-infection was assessed for (A) total and differential (B) macrophage, 
(C) neutrophil and (D) lymphocyte cell counts (n = 5− 11). Taqman PCR analysis for gene expression of TH2 
cytokines (E) interleukin-5 and (F) interleukin-13 in lung tissue is expressed as fold-change compared to 
vehicle-treated control and normalised to GAPDH housekeeping gene (n = 6). *p < 0.05 compared to vehicle 
lymphocytes. BALF; bronchoalveolar lavage fluid.
www.nature.com/scientificreports/
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Discussion
In this study, a significant increase in central airways resistance in response to MCh challenge was only observed 
in adult mice co-infected with SP and IAV during infancy, in contrast to mice infected with a single respiratory 
pathogen. In a previous study, residual lung function defects in adulthood were observed in mice that were chal-
lenged with IAV in infancy14. The differential response to IAV alone may reflect mouse and viral strain differ-
ences, where Balb/c mice inoculated with Mem/71 were previously been used, in contrast to this study where 
C57BL/6 mice infected with HKx31 were assessed. Histologically, there was no evidence for remodelling of the 
airways, with no increase in goblet cells or Muc5ac expression or increase in smooth muscle bulk. Functionally, 
airway smooth muscle appears to be normal as assessment of MCh constrictor responses in isolated lung slices 
were not altered in co-infected mice.
Since IAV-induced disruption of the airway-epithelial barrier has previously been reported to promote AHR 
due to increased MCh accessibility to smooth muscle, we also assessed epithelial integrity. Co-infection with viru-
lent strains of IAV and SP has been shown to lead to greater loss of basal epithelial cells and poor re-establishment 
of the normal airway epithelium during reparative processes21. However, histologically there was no evidence 
for disruption of lower airway epithelial barrier surrounding airways, and transcript expression of the epithelial 
integrity markers (ZO-1, occludin-1 and E-cadherin) was not altered in co-infected mice. In addition, the rel-
ative abundance of AT2 cells in adult mice did not differ between the treatment groups following co-infection 
during infancy. The strain of virus used in this study is considered to be moderately virulent, hence may not 
necessarily promote long term damage as seen with more virulent pandemic strains. Alternately, upper airway 
Figure 4. Increased airway resistance in vivo following neonatal co-infection. (A) Newtonian resistance 
(Rn), which is representative of central airways resistance was assessed via SCIREQ® Flexivent small-animal 
ventilator. Nebulised doses of methacholine (MCh) in injectable saline were delivered via tracheal cannula.  
(B) Maximal Rn response to MCh is expressed as % saline control response (n = 5− 12). *p < 0.05 compared to 
vehicle and to IAV treated mice.
www.nature.com/scientificreports/
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colonisation requires adhesion to the epithelial lining of the respiratory tract via binding to cell-surface carbohy-
drates. Increased upper airway carriage in co-infected mice may disrupt the barrier function of polarized upper 
airway epithelial cells to facilitate greater transmigration of allergens.
SP displays significant genetic diversity with over 90 serotypes and commonly inhabits the upper airways 
where it can lead to persistent carriage, particularly in infants where colonisation rates in excess of 60% have 
been reported22. Although there are multiple risk factors for impaired SP clearance, co-existence of respiratory 
viruses markedly increase pneumococcal load during the acute phase of infection and also facilitates transmis-
sion7. Here, we show in an infant model of co-infection, that IAV facilitates long term nasopharyngeal coloni-
sation into adulthood, in contrast to mice inoculated with SP alone, where the pneumococcus was cleared by 
day 40. Pneumococcal infection is associated with a robust acute inflammatory response, and clearance of SP 
Figure 5. Increased airway hysterestivity following neonatal co-infection. Tissue damping (G; (A,B)), tissue 
elastance (H; (C,D)) and tissue hysterestivity (η ; (E,F)) were also assessed with SCIREQ® Flexivent in response 
to nebulised doses of MCh (n = 5− 12). *p < 0.05 compared to vehicle treated mice.
www.nature.com/scientificreports/
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Figure 6. Neonatal co-infection does not induce mucus hyper-secretion or increased airway smooth 
muscle bulk. Representative images of immunohistochemistry shows Ab-PAS (A–D) and α -smooth muscle 
actin (α -SMA; (E–H) staining of lung tissue from adult mice exposed to infection in early life. (I) Taqman 
PCR analysis of mucin marker Muc5ac gene expression in lung tissue is expressed as fold-increase compared 
to vehicle-treated control and normalised to GAPDH housekeeping gene (n = 6). (J) Quantification of airway 
α -SMA staining (brown) is expressed as area of stain/basement membrane (BM) length (n = 5− 11).
www.nature.com/scientificreports/
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is dependent on recruitment of leukocytes to the airways and engagement of humoral-mediated immunity23. It 
has been established that during co-infection with IAV and SP, interferon-dependent anti-viral responses can 
alter acute cell-mediated immunity to SP leading to a marked increase in pneumococcal load24. Here, we show 
that infant IAV infection has long lasting consequences on pneumococcal colonisation of the upper airways into 
adulthood.
Acute inflammatory responses to IAV are also known to transiently alter lung function. Interestingly, mice 
deficient in neutrophils display impaired lung function associated with an increase in airway resistance, tissue 
damping and tissue elastance as a consequence of impaired viral clearance and more severe histopathology25. 
Hence, an appropriate acute inflammatory response can prevent significant structural changes underlying res-
piratory functional abnormalities. Infection of neutropenic mice was also characterized by an increase in lung 
oedema25. Consistent with this study, an increase in permeability of the alveolar–capillary barrier was related to 
AHR and this response was shown to be transient in adult mice as lung function normalised with resolution of 
inflammation, oedema and tissue repair13. In our study, inflammation had resolved with the exception of a small 
but significant increase in BAL lymphocytes in co-infected mice. The increase in lymphocytes was not associated 
with an increase in IL-5 or IL-13 expression; hence co-infection did not induce a classic TH2 response. SP is 
known to induce expansion of multiple T lymphocyte subsets including mucosal innate T cells that contribute to 
control of pneumococcus, and our data suggest that co-infection with IAV promotes lymphocyte accumulation. 
It has been previously shown that bacterial components of SP can initiate the accumulation of T regulatory cells, 
which suppress allergic airways disease in response to ovalbumin sensitisation and challenge26. In our model, the 
presence of SP did not confer protection to AHR, possibly as an allergic adjuvant was not used to initiate lung 
function abnormalities.
Prospective childhood cohorts have now identified viral respiratory infections as a major risk factor for devel-
oping persistent wheeze and asthma in individuals with co-existing aeroallergen sensitization27. Post natal lung 
growth represents an important susceptibility period where the combination of viral infections and aeroallergen 
sensitisation in children can lead to persistent pathological changes and respiratory dysfunction28. The role of 
Figure 7. Neonatal co-infection does not elicit hyperreactivity in vitro in lung slices. (A) Representative 
phase-contrast images and (B) time-course trace of an intrapumonary airway in mouse precision cut lung slice 
contracting to increasing concentrations of perfused methacholine (MCh). Time-course trace and (C) grouped 
data are expressed as % inital airway lumen area as calculated following greyscale analysis of airway lumen size 
(n = 3− 5).
www.nature.com/scientificreports/
1 0Scientific RepoRts | 6:22751 | DOI: 10.1038/srep22751
co-infection in this context is less clear; however there is emerging data to suggest that nasopharyngeal colonisa-
tion may increase risk of developing asthma. In a recent study, the presence of bacterial pathogens including SP in 
the nasopharyngeal compartment during infancy was identified as significant risk determinant for febrile lower 
respiratory infections and later asthma development29.
Hence, it is plausible that prevention of bacterial colonisation in infancy can contribute to the prevention of 
lower respiratory tract infections and persistent wheeze. This remains a challenging proposition using current 
strategies as a potential causal link between the use of antibiotics and development of asthma was identified, 
where disruption of the upper airway microbiome selects for resistant strains that are potentially more patho-
genic29. The pneumococcal vaccine can reduce risk; however, the niche created by eliminating vaccine-targeted 
serotypes can be replaced by other serotypes and pathogenic bacteria.
In summary, co-infection caused a significant increase in central airway resistance that was not associated with 
conventional airway remodelling that underlies AHR to nebulised MCh such as mucus overproduction, smooth 
muscle thickening or epithelial leakage. An increase in hysteresivity was observed in both IAV and co-infected 
Figure 8. Neonatal co-infection is not associated with airway epithelial disruption. Representative 
histological images (A–D) of Massons Trichrome (MT) staining of lung tissue from mice exposed to infection 
in early life. Quantification of epithelial thickness (E) is expressed as area of MT stain (purple)/basement 
membrane length (n = 5− 11). Taqman PCR analysis of epithelial integrity markers (F) ZO-1, (G) occludin-1 
and (H) E-Cadherin are expressed as fold-increase compared to vehicle-treated control and normalised to 
GAPDH housekeeping gene (n = 6).
www.nature.com/scientificreports/
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mice. Hence, co-infection in infancy may be causing distinct structural changes that contribute to ventilation 
heterogeneity, which persists into adulthood. Lung hysteresivity is a term used to reflect the mechanical coupling 
between energy dissipative forces and tissue-elastic properties in the parenchyma. Remodelling of the tissue 
increases hysteresivity in both emphysema and fibrosis in a way that correlates with the volume proportion of 
collagen, however the physical basis of this phenomenon is not well understood30. Our data suggests that there 
may be microstructural changes contributing to ventilation heterogeneity. Future studies should investigate the 
impact of co-infection on extracellular matrix components that contribute to the parenchymal architecture and 
also assess the consequences of combining infant co-infection with aeroallergen sensitisation.
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